{"transactions":[{"id":862552,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":62914,"kind":"person","name":"Haytaian Peter D","position":1,"cik":"0001608538","reported_name":"Haytaian Peter D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Pres Carelon & CarelonRx"}}],"security":"Common Stock","published_at":"2026-03-04T21:57:53.000Z","date":"2026-03-03","kind":"tax_withholding","planned":false,"acquired":false,"shares":446,"price":284.03,"value":126677.38,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK."}],"balance_after":27222,"source":{"system":"sec-edgar","filing":"0001608538-26-000002","document":"wk-form4_1772661470.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1156039/000160853826000002/wk-form4_1772661470.xml","form_type":"4"}},{"id":862551,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":62914,"kind":"person","name":"Haytaian Peter D","position":1,"cik":"0001608538","reported_name":"Haytaian Peter D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Pres Carelon & CarelonRx"}}],"security":"Common Stock","published_at":"2026-03-04T21:57:53.000Z","date":"2026-03-02","kind":"grant","planned":false,"acquired":true,"shares":2865,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents performance based restricted share units. Restrictions lapsed on 3/2/2026."}],"balance_after":27668,"source":{"system":"sec-edgar","filing":"0001608538-26-000002","document":"wk-form4_1772661470.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1156039/000160853826000002/wk-form4_1772661470.xml","form_type":"4"}},{"id":862550,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":62914,"kind":"person","name":"Haytaian Peter D","position":1,"cik":"0001608538","reported_name":"Haytaian Peter D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Pres Carelon & CarelonRx"}}],"security":"Common Stock","published_at":"2026-03-04T21:57:53.000Z","date":"2026-03-02","kind":"tax_withholding","planned":false,"acquired":false,"shares":1201,"price":294.07,"value":353178.07,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK."}],"balance_after":24803,"source":{"system":"sec-edgar","filing":"0001608538-26-000002","document":"wk-form4_1772661470.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1156039/000160853826000002/wk-form4_1772661470.xml","form_type":"4"}},{"id":1223451,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":62914,"kind":"person","name":"Haytaian Peter D","position":1,"cik":"0001608538","reported_name":"Haytaian Peter D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Pres Carelon & CarelonRx"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2025-03-05T21:48:33.000Z","date":"2025-03-03","kind":"grant","planned":false,"acquired":true,"shares":11549,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option represents a right to purchase a total of 11,549 shares, and is exercisable in three annual installments, with one installment of 3,849 shares and two installments of 3,850 shares each, beginning on 3/3/2026, which is the one-year anniversary of the option grant date."}],"balance_after":11549,"derivative":{"exercise_price":395.5,"expiration_date":"2035-03-03","underlying":"Common Stock","underlying_shares":11549},"source":{"system":"sec-edgar","filing":"0001156039-25-000026","document":"wk-form4_1741211306.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1156039/000115603925000026/wk-form4_1741211306.xml","form_type":"4"}},{"id":1223450,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":62914,"kind":"person","name":"Haytaian Peter D","position":1,"cik":"0001608538","reported_name":"Haytaian Peter D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Pres Carelon & CarelonRx"}}],"security":"Common Stock","published_at":"2025-03-05T21:48:33.000Z","date":"2025-03-03","kind":"grant","planned":false,"acquired":true,"shares":4213,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents performance based restricted share units. Restrictions lapse on 3/3/2025."}],"balance_after":26004,"source":{"system":"sec-edgar","filing":"0001156039-25-000026","document":"wk-form4_1741211306.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1156039/000115603925000026/wk-form4_1741211306.xml","form_type":"4"}},{"id":1223449,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":62914,"kind":"person","name":"Haytaian Peter D","position":1,"cik":"0001608538","reported_name":"Haytaian Peter D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Pres Carelon & CarelonRx"}}],"security":"Common Stock","published_at":"2025-03-05T21:48:33.000Z","date":"2025-03-03","kind":"grant","planned":false,"acquired":true,"shares":3035,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents restricted share units. Restrictions lapse as follows: 1,011 shares on 3/3/2026, and 1,012 shares each on 3/3/2027 and 3/3/2028."}],"balance_after":21791,"source":{"system":"sec-edgar","filing":"0001156039-25-000026","document":"wk-form4_1741211306.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1156039/000115603925000026/wk-form4_1741211306.xml","form_type":"4"}},{"id":1223448,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":62914,"kind":"person","name":"Haytaian Peter D","position":1,"cik":"0001608538","reported_name":"Haytaian Peter D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Pres Carelon & CarelonRx"}}],"security":"Common Stock","published_at":"2025-03-05T21:48:33.000Z","date":"2025-03-03","kind":"tax_withholding","planned":false,"acquired":false,"shares":2281,"price":395.5,"value":902135.5,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK."}],"balance_after":18756,"source":{"system":"sec-edgar","filing":"0001156039-25-000026","document":"wk-form4_1741211306.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1156039/000115603925000026/wk-form4_1741211306.xml","form_type":"4"}},{"id":1375791,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":62914,"kind":"person","name":"Haytaian Peter D","position":1,"cik":"0001608538","reported_name":"Haytaian Peter D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Pres Carelon & CarelonRx"}}],"security":"Common Stock","published_at":"2024-11-05T21:26:54.000Z","date":"2024-11-01","kind":"grant","planned":false,"acquired":true,"shares":3799,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents performance based restricted share units. Restrictions lapse on 11/1/2024."}],"balance_after":21037,"source":{"system":"sec-edgar","filing":"0001156039-24-000131","document":"wk-form4_1730842008.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1156039/000115603924000131/wk-form4_1730842008.xml","form_type":"4"}},{"id":1375790,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":62914,"kind":"person","name":"Haytaian Peter D","position":1,"cik":"0001608538","reported_name":"Haytaian Peter D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Pres Carelon & CarelonRx"}}],"security":"Common Stock","published_at":"2024-11-05T21:26:54.000Z","date":"2024-11-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":1649,"price":414.01,"value":682702.49,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK."}],"balance_after":17238,"source":{"system":"sec-edgar","filing":"0001156039-24-000131","document":"wk-form4_1730842008.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1156039/000115603924000131/wk-form4_1730842008.xml","form_type":"4"}},{"id":1598078,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":62914,"kind":"person","name":"Haytaian Peter D","position":1,"cik":"0001608538","reported_name":"Haytaian Peter D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Pres Carelon & CarelonRx"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2024-03-05T21:24:39.000Z","date":"2024-03-04","kind":"exercise","planned":true,"acquired":false,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"The option represents a right to purchase a total of 19,908 shares and is exercisable in six semi-annual installments of 3,318 shares each beginning on 9/1/2017, which is the six-month anniversary of the date on which the option was granted."}],"balance_after":4908,"derivative":{"exercise_price":166.97,"expiration_date":"2027-03-01","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001156039-24-000029","document":"wk-form4_1709673865.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1156039/000115603924000029/wk-form4_1709673865.xml","form_type":"4"}},{"id":1598077,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":62914,"kind":"person","name":"Haytaian Peter D","position":1,"cik":"0001608538","reported_name":"Haytaian Peter D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Pres Carelon & CarelonRx"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2024-03-05T21:24:39.000Z","date":"2024-03-01","kind":"grant","planned":true,"acquired":true,"shares":9280,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The option represents a right to purchase a total of 9,280 shares, and is exercisable in two  installments of 3,093 shares each, and one installment of 3,094 shares, beginning on 3/1/2025, which is the one-year anniversary of the option grant date."}],"balance_after":9280,"derivative":{"exercise_price":499.11,"expiration_date":"2034-03-01","underlying":"Common Stock","underlying_shares":9280},"source":{"system":"sec-edgar","filing":"0001156039-24-000029","document":"wk-form4_1709673865.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1156039/000115603924000029/wk-form4_1709673865.xml","form_type":"4"}},{"id":1598076,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":62914,"kind":"person","name":"Haytaian Peter D","position":1,"cik":"0001608538","reported_name":"Haytaian Peter D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Pres Carelon & CarelonRx"}}],"security":"Common Stock","published_at":"2024-03-05T21:24:39.000Z","date":"2024-03-04","kind":"sale","planned":true,"acquired":false,"shares":15000,"price":500.18,"value":7502700.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 4, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"This transaction was executed in multiple trades, each at the same price of $500.18. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares at which the transaction was effected."}],"balance_after":18887,"source":{"system":"sec-edgar","filing":"0001156039-24-000029","document":"wk-form4_1709673865.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1156039/000115603924000029/wk-form4_1709673865.xml","form_type":"4"}},{"id":1598075,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":62914,"kind":"person","name":"Haytaian Peter D","position":1,"cik":"0001608538","reported_name":"Haytaian Peter D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Pres Carelon & CarelonRx"}}],"security":"Common Stock","published_at":"2024-03-05T21:24:39.000Z","date":"2024-03-04","kind":"sale","planned":true,"acquired":false,"shares":1889,"price":500.18,"value":944840.02,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 4, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"This transaction was executed in multiple trades, each at the same price of $500.18. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares at which the transaction was effected."}],"balance_after":33887,"source":{"system":"sec-edgar","filing":"0001156039-24-000029","document":"wk-form4_1709673865.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1156039/000115603924000029/wk-form4_1709673865.xml","form_type":"4"}},{"id":1598074,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":62914,"kind":"person","name":"Haytaian Peter D","position":1,"cik":"0001608538","reported_name":"Haytaian Peter D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Pres Carelon & CarelonRx"}}],"security":"Common Stock","published_at":"2024-03-05T21:24:39.000Z","date":"2024-03-04","kind":"sale","planned":true,"acquired":false,"shares":4206,"price":500.18,"value":2103757.08,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 4, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"This transaction was executed in multiple trades, each at the same price of $500.18. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares at which the transaction was effected."}],"balance_after":35776,"source":{"system":"sec-edgar","filing":"0001156039-24-000029","document":"wk-form4_1709673865.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1156039/000115603924000029/wk-form4_1709673865.xml","form_type":"4"}},{"id":1598073,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":62914,"kind":"person","name":"Haytaian Peter D","position":1,"cik":"0001608538","reported_name":"Haytaian Peter D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Pres Carelon & CarelonRx"}}],"security":"Common Stock","published_at":"2024-03-05T21:24:39.000Z","date":"2024-03-04","kind":"exercise","planned":true,"acquired":true,"shares":15000,"price":166.97,"value":2504550.0,"ownership":{"direct":true},"balance_after":39982,"source":{"system":"sec-edgar","filing":"0001156039-24-000029","document":"wk-form4_1709673865.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1156039/000115603924000029/wk-form4_1709673865.xml","form_type":"4"}},{"id":1598072,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":62914,"kind":"person","name":"Haytaian Peter D","position":1,"cik":"0001608538","reported_name":"Haytaian Peter D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Pres Carelon & CarelonRx"}}],"security":"Common Stock","published_at":"2024-03-05T21:24:39.000Z","date":"2024-03-01","kind":"grant","planned":true,"acquired":true,"shares":9152,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents performance based restricted share units. Restrictions lapse on 3/1/2024."}],"balance_after":24982,"source":{"system":"sec-edgar","filing":"0001156039-24-000029","document":"wk-form4_1709673865.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1156039/000115603924000029/wk-form4_1709673865.xml","form_type":"4"}},{"id":1598071,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":62914,"kind":"person","name":"Haytaian Peter D","position":1,"cik":"0001608538","reported_name":"Haytaian Peter D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Pres Carelon & CarelonRx"}}],"security":"Common Stock","published_at":"2024-03-05T21:24:39.000Z","date":"2024-03-01","kind":"grant","planned":true,"acquired":true,"shares":2405,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents restricted share units. Restrictions lapse as follows:801 shares on 3/1/2025, and 802 shares each on 3/1/2026 and 3/1/2027."}],"balance_after":15830,"source":{"system":"sec-edgar","filing":"0001156039-24-000029","document":"wk-form4_1709673865.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1156039/000115603924000029/wk-form4_1709673865.xml","form_type":"4"}},{"id":1598070,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":62914,"kind":"person","name":"Haytaian Peter D","position":1,"cik":"0001608538","reported_name":"Haytaian Peter D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Pres Carelon & CarelonRx"}}],"security":"Common Stock","published_at":"2024-03-05T21:24:39.000Z","date":"2024-03-01","kind":"tax_withholding","planned":true,"acquired":false,"shares":4314,"price":499.11,"value":2153160.54,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK."}],"balance_after":13425,"source":{"system":"sec-edgar","filing":"0001156039-24-000029","document":"wk-form4_1709673865.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1156039/000115603924000029/wk-form4_1709673865.xml","form_type":"4"}},{"id":1750106,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":62914,"kind":"person","name":"Haytaian Peter D","position":1,"cik":"0001608538","reported_name":"Haytaian Peter D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Pres Carelon & CarelonRx"}}],"security":"Common Stock","published_at":"2023-11-03T20:44:27.000Z","date":"2023-11-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":154,"price":446.66,"value":68785.64,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK."}],"balance_after":17739,"source":{"system":"sec-edgar","filing":"0001156039-23-000115","document":"wk-form4_1699044259.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1156039/000115603923000115/wk-form4_1699044259.xml","form_type":"4"}},{"id":1975024,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":62914,"kind":"person","name":"Haytaian Peter D","position":1,"cik":"0001608538","reported_name":"Haytaian Peter D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Pres Carelon & CarelonRx"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2023-03-03T21:17:21.000Z","date":"2023-03-01","kind":"grant","acquired":true,"shares":8812,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option represents a right to purchase a total of 8,812 shares, and is exercisable in two installments of 2,937 shares each and one installment of 2,938 shares, beginning on 3/1/2024 which is the one-year anniversary of the option grant date."}],"balance_after":8812,"derivative":{"exercise_price":469.03,"expiration_date":"2033-03-01","underlying":"Common Stock","underlying_shares":8812},"source":{"system":"sec-edgar","filing":"0001156039-23-000026","document":"wf-form4_167787821928724.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1156039/000115603923000026/wf-form4_167787821928724.xml","form_type":"4"}},{"id":1975023,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":62914,"kind":"person","name":"Haytaian Peter D","position":1,"cik":"0001608538","reported_name":"Haytaian Peter D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Pres Carelon & CarelonRx"}}],"security":"Common Stock","published_at":"2023-03-03T21:17:21.000Z","date":"2023-03-02","kind":"tax_withholding","acquired":false,"shares":5469,"price":468.78,"value":2563757.82,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK."}],"balance_after":17893,"source":{"system":"sec-edgar","filing":"0001156039-23-000026","document":"wf-form4_167787821928724.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1156039/000115603923000026/wf-form4_167787821928724.xml","form_type":"4"}},{"id":1975022,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":62914,"kind":"person","name":"Haytaian Peter D","position":1,"cik":"0001608538","reported_name":"Haytaian Peter D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Pres Carelon & CarelonRx"}}],"security":"Common Stock","published_at":"2023-03-03T21:17:21.000Z","date":"2023-03-01","kind":"grant","acquired":true,"shares":9716,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents performance based restricted share units. Restrictions lapse on 3/2/2023."}],"balance_after":23362,"source":{"system":"sec-edgar","filing":"0001156039-23-000026","document":"wf-form4_167787821928724.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1156039/000115603923000026/wf-form4_167787821928724.xml","form_type":"4"}},{"id":1975021,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":62914,"kind":"person","name":"Haytaian Peter D","position":1,"cik":"0001608538","reported_name":"Haytaian Peter D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Pres Carelon & CarelonRx"}}],"security":"Common Stock","published_at":"2023-03-03T21:17:21.000Z","date":"2023-03-01","kind":"grant","acquired":true,"shares":2292,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents restricted share units. Restrictions lapse as follows: 764 shares each on 3/1/2024, 3/1/2025 and 3/1/2026."}],"balance_after":13646,"source":{"system":"sec-edgar","filing":"0001156039-23-000026","document":"wf-form4_167787821928724.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1156039/000115603923000026/wf-form4_167787821928724.xml","form_type":"4"}},{"id":1975020,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":62914,"kind":"person","name":"Haytaian Peter D","position":1,"cik":"0001608538","reported_name":"Haytaian Peter D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Pres Carelon & CarelonRx"}}],"security":"Common Stock","published_at":"2023-03-03T21:17:21.000Z","date":"2023-03-01","kind":"tax_withholding","acquired":false,"shares":607,"price":469.03,"value":284701.21,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK."}],"balance_after":11354,"source":{"system":"sec-edgar","filing":"0001156039-23-000026","document":"wf-form4_167787821928724.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1156039/000115603923000026/wf-form4_167787821928724.xml","form_type":"4"}},{"id":2126003,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":62914,"kind":"person","name":"Haytaian Peter D","position":1,"cik":"0001608538","reported_name":"Haytaian Peter D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Pres Carelon & IngenioRx"}}],"security":"Common Stock","published_at":"2022-11-03T21:07:10.000Z","date":"2022-11-01","kind":"tax_withholding","acquired":false,"shares":200,"price":544.53,"value":108906.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK."}],"balance_after":11961,"source":{"system":"sec-edgar","filing":"0001156039-22-000091","document":"wf-form4_166750960915281.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1156039/000115603922000091/wf-form4_166750960915281.xml","form_type":"4"}},{"id":2335872,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":62914,"kind":"person","name":"Haytaian Peter D","position":1,"cik":"0001608538","reported_name":"Haytaian Peter D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Pres., DBG & IngenioRx"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2022-03-14T20:36:48.000Z","date":"2022-03-10","kind":"exercise","acquired":false,"shares":1848,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"The option represents a right to purchase a total of 24,348 shares and is exercisable in six semi-annual installments, with six installments of 4,058 shares each beginning on September 1, 2016, which is the six-month anniversary of the date on which the option was granted."}],"balance_after":0,"derivative":{"exercise_price":131.8,"expiration_date":"2026-03-01","underlying":"Common Stock","underlying_shares":1848},"source":{"system":"sec-edgar","filing":"0001156039-22-000040","document":"wf-form4_164729006481345.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1156039/000115603922000040/wf-form4_164729006481345.xml","form_type":"4"}},{"id":2335871,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":62914,"kind":"person","name":"Haytaian Peter D","position":1,"cik":"0001608538","reported_name":"Haytaian Peter D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Pres., DBG & IngenioRx"}}],"security":"Common Stock","published_at":"2022-03-14T20:36:48.000Z","date":"2022-03-10","kind":"sale","acquired":false,"shares":40,"price":463.4,"value":18536.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 1, 2022."}],"balance_after":12161,"source":{"system":"sec-edgar","filing":"0001156039-22-000040","document":"wf-form4_164729006481345.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1156039/000115603922000040/wf-form4_164729006481345.xml","form_type":"4"}},{"id":2335870,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":62914,"kind":"person","name":"Haytaian Peter D","position":1,"cik":"0001608538","reported_name":"Haytaian Peter D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Pres., DBG & IngenioRx"}}],"security":"Common Stock","published_at":"2022-03-14T20:36:48.000Z","date":"2022-03-10","kind":"sale","acquired":false,"shares":1240,"price":462.73,"value":573785.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 1, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"This transaction was executed in multiple trades at prices ranging from $462.34 to $463.25. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":12201,"source":{"system":"sec-edgar","filing":"0001156039-22-000040","document":"wf-form4_164729006481345.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1156039/000115603922000040/wf-form4_164729006481345.xml","form_type":"4"}},{"id":2335869,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":62914,"kind":"person","name":"Haytaian Peter D","position":1,"cik":"0001608538","reported_name":"Haytaian Peter D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Pres., DBG & IngenioRx"}}],"security":"Common Stock","published_at":"2022-03-14T20:36:48.000Z","date":"2022-03-10","kind":"sale","acquired":false,"shares":5874,"price":461.72,"value":2712143.28,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 1, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"This transaction was executed in multiple trades at prices ranging from $461.27 to $462.26. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":13441,"source":{"system":"sec-edgar","filing":"0001156039-22-000040","document":"wf-form4_164729006481345.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1156039/000115603922000040/wf-form4_164729006481345.xml","form_type":"4"}},{"id":2335868,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":62914,"kind":"person","name":"Haytaian Peter D","position":1,"cik":"0001608538","reported_name":"Haytaian Peter D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Pres., DBG & IngenioRx"}}],"security":"Common Stock","published_at":"2022-03-14T20:36:48.000Z","date":"2022-03-10","kind":"sale","acquired":false,"shares":4105,"price":460.68,"value":1891091.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 1, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"This transaction was executed in multiple trades at prices ranging from $460.26 to $461.19. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":19315,"source":{"system":"sec-edgar","filing":"0001156039-22-000040","document":"wf-form4_164729006481345.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1156039/000115603922000040/wf-form4_164729006481345.xml","form_type":"4"}},{"id":2335867,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":62914,"kind":"person","name":"Haytaian Peter D","position":1,"cik":"0001608538","reported_name":"Haytaian Peter D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Pres., DBG & IngenioRx"}}],"security":"Common Stock","published_at":"2022-03-14T20:36:48.000Z","date":"2022-03-10","kind":"sale","acquired":false,"shares":4274,"price":459.75,"value":1964971.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 1, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $459.25 to $460.24. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":23420,"source":{"system":"sec-edgar","filing":"0001156039-22-000040","document":"wf-form4_164729006481345.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1156039/000115603922000040/wf-form4_164729006481345.xml","form_type":"4"}},{"id":2335866,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":62914,"kind":"person","name":"Haytaian Peter D","position":1,"cik":"0001608538","reported_name":"Haytaian Peter D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Pres., DBG & IngenioRx"}}],"security":"Common Stock","published_at":"2022-03-14T20:36:48.000Z","date":"2022-03-10","kind":"sale","acquired":false,"shares":2170,"price":458.68,"value":995335.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 1, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $458.18 to $459.13. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":27694,"source":{"system":"sec-edgar","filing":"0001156039-22-000040","document":"wf-form4_164729006481345.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1156039/000115603922000040/wf-form4_164729006481345.xml","form_type":"4"}},{"id":2335865,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":62914,"kind":"person","name":"Haytaian Peter D","position":1,"cik":"0001608538","reported_name":"Haytaian Peter D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Pres., DBG & IngenioRx"}}],"security":"Common Stock","published_at":"2022-03-14T20:36:48.000Z","date":"2022-03-10","kind":"exercise","acquired":true,"shares":1848,"price":131.8,"value":243566.4,"ownership":{"direct":true},"balance_after":29864,"source":{"system":"sec-edgar","filing":"0001156039-22-000040","document":"wf-form4_164729006481345.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1156039/000115603922000040/wf-form4_164729006481345.xml","form_type":"4"}},{"id":2355633,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":62914,"kind":"person","name":"Haytaian Peter D","position":1,"cik":"0001608538","reported_name":"Haytaian Peter D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Pres., DBG & IngenioRx"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2022-03-03T21:43:22.000Z","date":"2022-03-01","kind":"grant","acquired":true,"shares":8832,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option represents a right to purchase a total of 8,832 shares, and is exercisable in three annual installments of 2,944 shares each, beginning on 3/1/2023, which is the one-year anniversary of the option grant date."}],"balance_after":8832,"derivative":{"exercise_price":451.5,"expiration_date":"2032-03-01","underlying":"Common Stock","underlying_shares":8832},"source":{"system":"sec-edgar","filing":"0001156039-22-000021","document":"wf-form4_164634376392611.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1156039/000115603922000021/wf-form4_164634376392611.xml","form_type":"4"}},{"id":2355632,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":62914,"kind":"person","name":"Haytaian Peter D","position":1,"cik":"0001608538","reported_name":"Haytaian Peter D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Pres., DBG & IngenioRx"}}],"security":"Common Stock","published_at":"2022-03-03T21:43:22.000Z","date":"2022-03-02","kind":"tax_withholding","acquired":false,"shares":493,"price":463.49,"value":228500.57,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK."}],"balance_after":28016,"source":{"system":"sec-edgar","filing":"0001156039-22-000021","document":"wf-form4_164634376392611.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1156039/000115603922000021/wf-form4_164634376392611.xml","form_type":"4"}},{"id":2355631,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":62914,"kind":"person","name":"Haytaian Peter D","position":1,"cik":"0001608538","reported_name":"Haytaian Peter D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Pres., DBG & IngenioRx"}}],"security":"Common Stock","published_at":"2022-03-03T21:43:22.000Z","date":"2022-03-01","kind":"grant","acquired":true,"shares":8250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents performance based restricted share units. Restrictions lapse on 3/1/2022."}],"balance_after":28509,"source":{"system":"sec-edgar","filing":"0001156039-22-000021","document":"wf-form4_164634376392611.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1156039/000115603922000021/wf-form4_164634376392611.xml","form_type":"4"}},{"id":2355630,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":62914,"kind":"person","name":"Haytaian Peter D","position":1,"cik":"0001608538","reported_name":"Haytaian Peter D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Pres., DBG & IngenioRx"}}],"security":"Common Stock","published_at":"2022-03-03T21:43:22.000Z","date":"2022-03-01","kind":"grant","acquired":true,"shares":2215,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents restricted share units. Restrictions lapse as follows: 738 shares each on 3/1/2023 and 3/1/2024, and 739 shares on 3/1/2025."}],"balance_after":20259,"source":{"system":"sec-edgar","filing":"0001156039-22-000021","document":"wf-form4_164634376392611.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1156039/000115603922000021/wf-form4_164634376392611.xml","form_type":"4"}},{"id":2355629,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":62914,"kind":"person","name":"Haytaian Peter D","position":1,"cik":"0001608538","reported_name":"Haytaian Peter D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Pres., DBG & IngenioRx"}}],"security":"Common Stock","published_at":"2022-03-03T21:43:22.000Z","date":"2022-03-01","kind":"tax_withholding","acquired":false,"shares":4667,"price":451.5,"value":2107150.5,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK."}],"balance_after":18044,"source":{"system":"sec-edgar","filing":"0001156039-22-000021","document":"wf-form4_164634376392611.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1156039/000115603922000021/wf-form4_164634376392611.xml","form_type":"4"}},{"id":2526934,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":62914,"kind":"person","name":"Haytaian Peter D","position":1,"cik":"0001608538","reported_name":"Haytaian Peter D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Pres., DBG & IngenioRx"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2021-11-03T20:31:21.000Z","date":"2021-11-01","kind":"grant","acquired":true,"shares":4786,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option represents a right to purchase a total of 4,786 shares, and is exercisable in three annual installments, with two installments of 1,595 shares each and one installment of 1,596 shares, beginning on 11/01/2022, which is the one-year anniversary of the option grant date."}],"balance_after":4786,"derivative":{"exercise_price":428.76,"expiration_date":"2031-11-01","underlying":"Common Stock","underlying_shares":4786},"source":{"system":"sec-edgar","filing":"0001156039-21-000097","document":"wf-form4_163597146574460.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1156039/000115603921000097/wf-form4_163597146574460.xml","form_type":"4"}},{"id":2526933,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":62914,"kind":"person","name":"Haytaian Peter D","position":1,"cik":"0001608538","reported_name":"Haytaian Peter D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Pres., DBG & IngenioRx"}}],"security":"Common Stock","published_at":"2021-11-03T20:31:21.000Z","date":"2021-11-01","kind":"grant","acquired":true,"shares":1167,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted share units. Restrictions lapse as follows: 389 shares each on 11/1/2022, 11/1/2023 and 11/1/2024."}],"balance_after":22711,"source":{"system":"sec-edgar","filing":"0001156039-21-000097","document":"wf-form4_163597146574460.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1156039/000115603921000097/wf-form4_163597146574460.xml","form_type":"4"}},{"id":2723458,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":62914,"kind":"person","name":"Haytaian Peter D","position":1,"cik":"0001608538","reported_name":"Haytaian Peter D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & President, Commercial"}}],"security":"Common Stock","published_at":"2021-05-07T20:31:34.000Z","date":"2018-10-31","kind":"sale","acquired":false,"shares":1000,"price":270,"value":270000.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on July 26, 2018. Due to administrative error, this transaction was not previously reported on a Form 4. As a result, the reporting person's Forms 4 filed since the date of this transaction have overstated the reporting person's ownership by 1,000 shares."}],"balance_after":21544,"source":{"system":"sec-edgar","filing":"0001156039-21-000043","document":"wf-form4_162041945933437.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1156039/000115603921000043/wf-form4_162041945933437.xml","form_type":"4"}},{"id":2775132,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":62914,"kind":"person","name":"Haytaian Peter D","position":1,"cik":"0001608538","reported_name":"Haytaian Peter D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & President, Commercial"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2021-03-23T20:31:14.000Z","date":"2021-03-22","kind":"exercise","acquired":false,"shares":22500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F9","text":"The option represents a right to purchase a total of 24,348 shares, and is exercisable in six semi-annual installments of 4,058 shares each, beginning on September 1, 2016, which is the six-month anniversary of the option grant date."}],"balance_after":1848,"derivative":{"exercise_price":131.8,"expiration_date":"2026-03-01","underlying":"Common Stock","underlying_shares":22500},"source":{"system":"sec-edgar","filing":"0001156039-21-000038","document":"wf-form4_161653145347931.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1156039/000115603921000038/wf-form4_161653145347931.xml","form_type":"4"}},{"id":2775131,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":62914,"kind":"person","name":"Haytaian Peter D","position":1,"cik":"0001608538","reported_name":"Haytaian Peter D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & President, Commercial"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2021-03-23T20:31:14.000Z","date":"2021-03-22","kind":"exercise","acquired":false,"shares":15593,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"The option represents a right to purchase a total of 22,353 shares and is exercisable in six semi-annual installments, with three installments of 3,725 shares each and three  installments of 3,726 shares each beginning on September 2, 2015, which is the six-month anniversary of the date on which the option was granted"}],"balance_after":0,"derivative":{"exercise_price":146.93,"expiration_date":"2025-03-02","underlying":"Common Stock","underlying_shares":15593},"source":{"system":"sec-edgar","filing":"0001156039-21-000038","document":"wf-form4_161653145347931.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1156039/000115603921000038/wf-form4_161653145347931.xml","form_type":"4"}},{"id":2775130,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":62914,"kind":"person","name":"Haytaian Peter D","position":1,"cik":"0001608538","reported_name":"Haytaian Peter D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & President, Commercial"}}],"security":"Common Stock","published_at":"2021-03-23T20:31:14.000Z","date":"2021-03-22","kind":"sale","acquired":false,"shares":2329,"price":352.84,"value":821764.36,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February, 1, 2021."}],"balance_after":22544,"source":{"system":"sec-edgar","filing":"0001156039-21-000038","document":"wf-form4_161653145347931.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1156039/000115603921000038/wf-form4_161653145347931.xml","form_type":"4"}},{"id":2775129,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":62914,"kind":"person","name":"Haytaian Peter D","position":1,"cik":"0001608538","reported_name":"Haytaian Peter D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & President, Commercial"}}],"security":"Common Stock","published_at":"2021-03-23T20:31:14.000Z","date":"2021-03-22","kind":"sale","acquired":false,"shares":400,"price":351.32,"value":140528.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February, 1, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"This transaction was executed in multiple trades at prices ranging from $350.99 to $351.54. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":24873,"source":{"system":"sec-edgar","filing":"0001156039-21-000038","document":"wf-form4_161653145347931.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1156039/000115603921000038/wf-form4_161653145347931.xml","form_type":"4"}},{"id":2775128,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":62914,"kind":"person","name":"Haytaian Peter D","position":1,"cik":"0001608538","reported_name":"Haytaian Peter D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & President, Commercial"}}],"security":"Common Stock","published_at":"2021-03-23T20:31:14.000Z","date":"2021-03-22","kind":"sale","acquired":false,"shares":7891,"price":350.21,"value":2763507.11,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February, 1, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"This transaction was executed in multiple trades at prices ranging from $349.97 to $350.72. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":25273,"source":{"system":"sec-edgar","filing":"0001156039-21-000038","document":"wf-form4_161653145347931.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1156039/000115603921000038/wf-form4_161653145347931.xml","form_type":"4"}},{"id":2775127,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":62914,"kind":"person","name":"Haytaian Peter D","position":1,"cik":"0001608538","reported_name":"Haytaian Peter D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & President, Commercial"}}],"security":"Common Stock","published_at":"2021-03-23T20:31:14.000Z","date":"2021-03-22","kind":"sale","acquired":false,"shares":26777,"price":349.53,"value":9359364.81,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February, 1, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"This transaction was executed in multiple trades at prices ranging from $348.97 to $349.94. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":33164,"source":{"system":"sec-edgar","filing":"0001156039-21-000038","document":"wf-form4_161653145347931.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1156039/000115603921000038/wf-form4_161653145347931.xml","form_type":"4"}},{"id":2775126,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":62914,"kind":"person","name":"Haytaian Peter D","position":1,"cik":"0001608538","reported_name":"Haytaian Peter D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & President, Commercial"}}],"security":"Common Stock","published_at":"2021-03-23T20:31:14.000Z","date":"2021-03-22","kind":"sale","acquired":false,"shares":12416,"price":348.52,"value":4327224.32,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February, 1, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"This transaction was executed in multiple trades at prices ranging from $347.95 to $348.91. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":59941,"source":{"system":"sec-edgar","filing":"0001156039-21-000038","document":"wf-form4_161653145347931.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1156039/000115603921000038/wf-form4_161653145347931.xml","form_type":"4"}},{"id":2775125,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":62914,"kind":"person","name":"Haytaian Peter D","position":1,"cik":"0001608538","reported_name":"Haytaian Peter D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & President, Commercial"}}],"security":"Common Stock","published_at":"2021-03-23T20:31:14.000Z","date":"2021-03-22","kind":"sale","acquired":false,"shares":9387,"price":347.44,"value":3261419.28,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February, 1, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $346.93 to $347.91. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":72357,"source":{"system":"sec-edgar","filing":"0001156039-21-000038","document":"wf-form4_161653145347931.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1156039/000115603921000038/wf-form4_161653145347931.xml","form_type":"4"}},{"id":2775124,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":62914,"kind":"person","name":"Haytaian Peter D","position":1,"cik":"0001608538","reported_name":"Haytaian Peter D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & President, Commercial"}}],"security":"Common Stock","published_at":"2021-03-23T20:31:14.000Z","date":"2021-03-22","kind":"sale","acquired":false,"shares":300,"price":345.59,"value":103677.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February, 1, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $345.53 to $345.66. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":81744,"source":{"system":"sec-edgar","filing":"0001156039-21-000038","document":"wf-form4_161653145347931.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1156039/000115603921000038/wf-form4_161653145347931.xml","form_type":"4"}},{"id":2775123,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":62914,"kind":"person","name":"Haytaian Peter D","position":1,"cik":"0001608538","reported_name":"Haytaian Peter D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & President, Commercial"}}],"security":"Common Stock","published_at":"2021-03-23T20:31:14.000Z","date":"2021-03-22","kind":"exercise","acquired":true,"shares":22500,"price":131.8,"value":2965500.0,"ownership":{"direct":true},"balance_after":82044,"source":{"system":"sec-edgar","filing":"0001156039-21-000038","document":"wf-form4_161653145347931.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1156039/000115603921000038/wf-form4_161653145347931.xml","form_type":"4"}},{"id":2775122,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":62914,"kind":"person","name":"Haytaian Peter D","position":1,"cik":"0001608538","reported_name":"Haytaian Peter D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & President, Commercial"}}],"security":"Common Stock","published_at":"2021-03-23T20:31:14.000Z","date":"2021-03-22","kind":"exercise","acquired":true,"shares":15593,"price":146.93,"value":2291079.49,"ownership":{"direct":true},"balance_after":59544,"source":{"system":"sec-edgar","filing":"0001156039-21-000038","document":"wf-form4_161653145347931.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1156039/000115603921000038/wf-form4_161653145347931.xml","form_type":"4"}},{"id":2814784,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":62914,"kind":"person","name":"Haytaian Peter D","position":1,"cik":"0001608538","reported_name":"Haytaian Peter D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & President, Commercial"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2021-03-03T21:31:20.000Z","date":"2021-03-01","kind":"grant","acquired":true,"shares":11533,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option represents a right to purchase a total of 11,533 shares, and is exercisable in three annual installments, with two installments of 3,844 shares each and one installment of 3,845 shares, beginning on 3/1/2022, which is the one-year anniversary of the option grant date."}],"balance_after":11533,"derivative":{"exercise_price":311.48,"expiration_date":"2031-03-01","underlying":"Common Stock","underlying_shares":11533},"source":{"system":"sec-edgar","filing":"0001156039-21-000023","document":"wf-form4_161480704164761.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1156039/000115603921000023/wf-form4_161480704164761.xml","form_type":"4"}},{"id":2814783,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":62914,"kind":"person","name":"Haytaian Peter D","position":1,"cik":"0001608538","reported_name":"Haytaian Peter D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & President, Commercial"}}],"security":"Common Stock","published_at":"2021-03-03T21:31:20.000Z","date":"2021-03-02","kind":"tax_withholding","acquired":false,"shares":492,"price":311.66,"value":153336.72,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK."}],"balance_after":43951,"source":{"system":"sec-edgar","filing":"0001156039-21-000023","document":"wf-form4_161480704164761.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1156039/000115603921000023/wf-form4_161480704164761.xml","form_type":"4"}},{"id":2814782,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":62914,"kind":"person","name":"Haytaian Peter D","position":1,"cik":"0001608538","reported_name":"Haytaian Peter D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & President, Commercial"}}],"security":"Common Stock","published_at":"2021-03-03T21:31:20.000Z","date":"2021-03-01","kind":"grant","acquired":true,"shares":23222,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents performance based restricted share units. Restrictions lapse on 3/1/2021."}],"balance_after":44443,"source":{"system":"sec-edgar","filing":"0001156039-21-000023","document":"wf-form4_161480704164761.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1156039/000115603921000023/wf-form4_161480704164761.xml","form_type":"4"}},{"id":2814781,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":62914,"kind":"person","name":"Haytaian Peter D","position":1,"cik":"0001608538","reported_name":"Haytaian Peter D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & President, Commercial"}}],"security":"Common Stock","published_at":"2021-03-03T21:31:20.000Z","date":"2021-03-01","kind":"grant","acquired":true,"shares":2810,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents restricted share units. Restrictions lapse as follows: 936 shares on 3/1/2022, and 937 shares each on 3/1/2023 and 3/1/2024."}],"balance_after":21221,"source":{"system":"sec-edgar","filing":"0001156039-21-000023","document":"wf-form4_161480704164761.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1156039/000115603921000023/wf-form4_161480704164761.xml","form_type":"4"}},{"id":2814780,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":62914,"kind":"person","name":"Haytaian Peter D","position":1,"cik":"0001608538","reported_name":"Haytaian Peter D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & President, Commercial"}}],"security":"Common Stock","published_at":"2021-03-03T21:31:20.000Z","date":"2021-03-01","kind":"tax_withholding","acquired":false,"shares":14231,"price":311.48,"value":4432671.88,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK."}],"balance_after":18411,"source":{"system":"sec-edgar","filing":"0001156039-21-000023","document":"wf-form4_161480704164761.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1156039/000115603921000023/wf-form4_161480704164761.xml","form_type":"4"}},{"id":2940511,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":62914,"kind":"person","name":"Haytaian Peter D","position":1,"cik":"0001608538","reported_name":"Haytaian Peter D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & President, Commercial"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2020-12-17T21:34:04.000Z","date":"2020-12-15","kind":"exercise","acquired":false,"shares":5833,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option represents a right to purchase a total of 22,353 shares, and is exercisable in six semi-annual installments with three installment of 3,725 shares and three installments of 3,726 shares each beginning on September 2, 2015, which is the six-month anniversary of the date on which the option was granted."}],"balance_after":15593,"derivative":{"exercise_price":146.93,"expiration_date":"2025-03-02","underlying":"Common Stock","underlying_shares":5833},"source":{"system":"sec-edgar","filing":"0001156039-20-000105","document":"wf-form4_160824083142314.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1156039/000115603920000105/wf-form4_160824083142314.xml","form_type":"4"}},{"id":2940510,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":62914,"kind":"person","name":"Haytaian Peter D","position":1,"cik":"0001608538","reported_name":"Haytaian Peter D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & President, Commercial"}}],"security":"Common Stock","published_at":"2020-12-17T21:34:04.000Z","date":"2020-12-15","kind":"sale","acquired":false,"shares":100,"price":313.42,"value":31342.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August, 14, 2020."}],"balance_after":32642,"source":{"system":"sec-edgar","filing":"0001156039-20-000105","document":"wf-form4_160824083142314.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1156039/000115603920000105/wf-form4_160824083142314.xml","form_type":"4"}},{"id":2940509,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":62914,"kind":"person","name":"Haytaian Peter D","position":1,"cik":"0001608538","reported_name":"Haytaian Peter D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & President, Commercial"}}],"security":"Common Stock","published_at":"2020-12-17T21:34:04.000Z","date":"2020-12-15","kind":"sale","acquired":false,"shares":3836,"price":312.76,"value":1199747.36,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August, 14, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $312.30 to $313.11. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":32742,"source":{"system":"sec-edgar","filing":"0001156039-20-000105","document":"wf-form4_160824083142314.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1156039/000115603920000105/wf-form4_160824083142314.xml","form_type":"4"}},{"id":2940508,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":62914,"kind":"person","name":"Haytaian Peter D","position":1,"cik":"0001608538","reported_name":"Haytaian Peter D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & President, Commercial"}}],"security":"Common Stock","published_at":"2020-12-17T21:34:04.000Z","date":"2020-12-15","kind":"sale","acquired":false,"shares":1897,"price":312.01,"value":591882.97,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August, 14, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $311.26 to $312.22. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":36578,"source":{"system":"sec-edgar","filing":"0001156039-20-000105","document":"wf-form4_160824083142314.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1156039/000115603920000105/wf-form4_160824083142314.xml","form_type":"4"}},{"id":2940507,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":62914,"kind":"person","name":"Haytaian Peter D","position":1,"cik":"0001608538","reported_name":"Haytaian Peter D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & President, Commercial"}}],"security":"Common Stock","published_at":"2020-12-17T21:34:04.000Z","date":"2020-12-15","kind":"exercise","acquired":true,"shares":5833,"price":146.93,"value":857042.69,"ownership":{"direct":true},"balance_after":38475,"source":{"system":"sec-edgar","filing":"0001156039-20-000105","document":"wf-form4_160824083142314.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1156039/000115603920000105/wf-form4_160824083142314.xml","form_type":"4"}},{"id":2975705,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":62914,"kind":"person","name":"Haytaian Peter D","position":1,"cik":"0001608538","reported_name":"Haytaian Peter D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & President, Commercial"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2020-11-18T21:32:36.000Z","date":"2020-11-16","kind":"exercise","acquired":false,"shares":927,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F9","text":"The option represents a right to purchase a total of 22,353 shares, and is exercisable in six semi-annual installments with three installments of 3,725 shares each and three installments of 3,726 shares each beginning on September 2, 2015, which is the six-month anniversary of the option grant date."}],"balance_after":21426,"derivative":{"exercise_price":146.93,"expiration_date":"2025-03-02","underlying":"Common Stock","underlying_shares":927},"source":{"system":"sec-edgar","filing":"0001156039-20-000095","document":"wf-form4_160573513891253.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1156039/000115603920000095/wf-form4_160573513891253.xml","form_type":"4"}},{"id":2975704,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":62914,"kind":"person","name":"Haytaian Peter D","position":1,"cik":"0001608538","reported_name":"Haytaian Peter D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & President, Commercial"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2020-11-18T21:32:36.000Z","date":"2020-11-16","kind":"exercise","acquired":false,"shares":781,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"The option represents a right to purchase a total of 10,127 shares, and is exercisable in six semi-annual installments with one installment of 1,687 shares and five installments of 1,688 shares each beginning on November 1, 2014, which is the six-month anniversary of the date on which the option was granted."}],"balance_after":0,"derivative":{"exercise_price":100.77,"expiration_date":"2021-05-01","underlying":"Common Stock","underlying_shares":781},"source":{"system":"sec-edgar","filing":"0001156039-20-000095","document":"wf-form4_160573513891253.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1156039/000115603920000095/wf-form4_160573513891253.xml","form_type":"4"}},{"id":2975703,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":62914,"kind":"person","name":"Haytaian Peter D","position":1,"cik":"0001608538","reported_name":"Haytaian Peter D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & President, Commercial"}}],"security":"Common Stock","published_at":"2020-11-18T21:32:36.000Z","date":"2020-11-16","kind":"sale","acquired":false,"shares":300,"price":337,"value":101100.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 14, 2020."}],"balance_after":32642,"source":{"system":"sec-edgar","filing":"0001156039-20-000095","document":"wf-form4_160573513891253.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1156039/000115603920000095/wf-form4_160573513891253.xml","form_type":"4"}},{"id":2975702,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":62914,"kind":"person","name":"Haytaian Peter D","position":1,"cik":"0001608538","reported_name":"Haytaian Peter D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & President, Commercial"}}],"security":"Common Stock","published_at":"2020-11-18T21:32:36.000Z","date":"2020-11-16","kind":"sale","acquired":false,"shares":675,"price":335.92,"value":226746.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 14, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"This transaction was executed in multiple trades at prices ranging from $335.91 to $335.92. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":32942,"source":{"system":"sec-edgar","filing":"0001156039-20-000095","document":"wf-form4_160573513891253.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1156039/000115603920000095/wf-form4_160573513891253.xml","form_type":"4"}},{"id":2975701,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":62914,"kind":"person","name":"Haytaian Peter D","position":1,"cik":"0001608538","reported_name":"Haytaian Peter D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & President, Commercial"}}],"security":"Common Stock","published_at":"2020-11-18T21:32:36.000Z","date":"2020-11-16","kind":"sale","acquired":false,"shares":1193,"price":334.87,"value":399499.91,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 14, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"This transaction was executed in multiple trades at prices ranging from $334.77 to $334.95. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":33617,"source":{"system":"sec-edgar","filing":"0001156039-20-000095","document":"wf-form4_160573513891253.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1156039/000115603920000095/wf-form4_160573513891253.xml","form_type":"4"}},{"id":2975700,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":62914,"kind":"person","name":"Haytaian Peter D","position":1,"cik":"0001608538","reported_name":"Haytaian Peter D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & President, Commercial"}}],"security":"Common Stock","published_at":"2020-11-18T21:32:36.000Z","date":"2020-11-16","kind":"sale","acquired":false,"shares":1200,"price":333.97,"value":400764.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 14, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"This transaction was executed in multiple trades at prices ranging from $333.72 to $334.57. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":34810,"source":{"system":"sec-edgar","filing":"0001156039-20-000095","document":"wf-form4_160573513891253.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1156039/000115603920000095/wf-form4_160573513891253.xml","form_type":"4"}},{"id":2975699,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":62914,"kind":"person","name":"Haytaian Peter D","position":1,"cik":"0001608538","reported_name":"Haytaian Peter D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & President, Commercial"}}],"security":"Common Stock","published_at":"2020-11-18T21:32:36.000Z","date":"2020-11-16","kind":"sale","acquired":false,"shares":1056,"price":332.86,"value":351500.16,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 14, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"This transaction was executed in multiple trades at prices ranging from $332.54 to $333.16. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":36010,"source":{"system":"sec-edgar","filing":"0001156039-20-000095","document":"wf-form4_160573513891253.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1156039/000115603920000095/wf-form4_160573513891253.xml","form_type":"4"}},{"id":2975698,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":62914,"kind":"person","name":"Haytaian Peter D","position":1,"cik":"0001608538","reported_name":"Haytaian Peter D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & President, Commercial"}}],"security":"Common Stock","published_at":"2020-11-18T21:32:36.000Z","date":"2020-11-16","kind":"sale","acquired":false,"shares":400,"price":331.92,"value":132768.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 14, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $331.44 to $332.27. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":37066,"source":{"system":"sec-edgar","filing":"0001156039-20-000095","document":"wf-form4_160573513891253.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1156039/000115603920000095/wf-form4_160573513891253.xml","form_type":"4"}},{"id":2975697,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":62914,"kind":"person","name":"Haytaian Peter D","position":1,"cik":"0001608538","reported_name":"Haytaian Peter D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & President, Commercial"}}],"security":"Common Stock","published_at":"2020-11-18T21:32:36.000Z","date":"2020-11-16","kind":"sale","acquired":false,"shares":1010,"price":330.77,"value":334077.7,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 14, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $330.31 to $331.04. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":37466,"source":{"system":"sec-edgar","filing":"0001156039-20-000095","document":"wf-form4_160573513891253.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1156039/000115603920000095/wf-form4_160573513891253.xml","form_type":"4"}},{"id":2975696,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":62914,"kind":"person","name":"Haytaian Peter D","position":1,"cik":"0001608538","reported_name":"Haytaian Peter D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & President, Commercial"}}],"security":"Common Stock","published_at":"2020-11-18T21:32:36.000Z","date":"2020-11-16","kind":"exercise","acquired":true,"shares":927,"price":146.93,"value":136204.11,"ownership":{"direct":true},"balance_after":38476,"source":{"system":"sec-edgar","filing":"0001156039-20-000095","document":"wf-form4_160573513891253.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1156039/000115603920000095/wf-form4_160573513891253.xml","form_type":"4"}},{"id":2975695,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":62914,"kind":"person","name":"Haytaian Peter D","position":1,"cik":"0001608538","reported_name":"Haytaian Peter D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & President, Commercial"}}],"security":"Common Stock","published_at":"2020-11-18T21:32:36.000Z","date":"2020-11-16","kind":"exercise","acquired":true,"shares":781,"price":100.77,"value":78701.37,"ownership":{"direct":true},"balance_after":37549,"source":{"system":"sec-edgar","filing":"0001156039-20-000095","document":"wf-form4_160573513891253.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1156039/000115603920000095/wf-form4_160573513891253.xml","form_type":"4"}},{"id":3004245,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":62914,"kind":"person","name":"Haytaian Peter D","position":1,"cik":"0001608538","reported_name":"Haytaian Peter D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & President, Commercial"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2020-10-19T20:31:51.000Z","date":"2020-10-15","kind":"exercise","acquired":false,"shares":4667,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"The option represents a right to purchase a total of 10,127 shares, and is exercisable in six semi-annual installments with one installment of 1,687 shares and five installments of 1,688 shares each beginning on November 1, 2014, which is the six-month anniversary of the date on which the option was granted."}],"balance_after":781,"derivative":{"exercise_price":100.77,"expiration_date":"2021-05-01","underlying":"Common Stock","underlying_shares":4667},"source":{"system":"sec-edgar","filing":"0001156039-20-000086","document":"wf-form4_160313949706885.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1156039/000115603920000086/wf-form4_160313949706885.xml","form_type":"4"}},{"id":3004244,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":62914,"kind":"person","name":"Haytaian Peter D","position":1,"cik":"0001608538","reported_name":"Haytaian Peter D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & President, Commercial"}}],"security":"Common Stock","published_at":"2020-10-19T20:31:51.000Z","date":"2020-10-15","kind":"sale","acquired":false,"shares":1167,"price":295,"value":344265.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 14, 2020."}],"balance_after":36768,"source":{"system":"sec-edgar","filing":"0001156039-20-000086","document":"wf-form4_160313949706885.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1156039/000115603920000086/wf-form4_160313949706885.xml","form_type":"4"}},{"id":3004243,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":62914,"kind":"person","name":"Haytaian Peter D","position":1,"cik":"0001608538","reported_name":"Haytaian Peter D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & President, Commercial"}}],"security":"Common Stock","published_at":"2020-10-19T20:31:51.000Z","date":"2020-10-15","kind":"sale","acquired":false,"shares":147,"price":293.98,"value":43215.06,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 14, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"This transaction was executed in multiple trades at prices ranging from $293.87 to $294.04. The price reported reflects the weighted average sale price."}],"balance_after":37935,"source":{"system":"sec-edgar","filing":"0001156039-20-000086","document":"wf-form4_160313949706885.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1156039/000115603920000086/wf-form4_160313949706885.xml","form_type":"4"}},{"id":3004242,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":62914,"kind":"person","name":"Haytaian Peter D","position":1,"cik":"0001608538","reported_name":"Haytaian Peter D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & President, Commercial"}}],"security":"Common Stock","published_at":"2020-10-19T20:31:51.000Z","date":"2020-10-15","kind":"sale","acquired":false,"shares":1120,"price":293.33,"value":328529.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 14, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"This transaction was executed in multiple trades at prices ranging from $292.75 to $293.64. The price reported reflects the weighted average sale price."}],"balance_after":38082,"source":{"system":"sec-edgar","filing":"0001156039-20-000086","document":"wf-form4_160313949706885.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1156039/000115603920000086/wf-form4_160313949706885.xml","form_type":"4"}},{"id":3004241,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":62914,"kind":"person","name":"Haytaian Peter D","position":1,"cik":"0001608538","reported_name":"Haytaian Peter D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & President, Commercial"}}],"security":"Common Stock","published_at":"2020-10-19T20:31:51.000Z","date":"2020-10-15","kind":"sale","acquired":false,"shares":1600,"price":292.13,"value":467408.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 14, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"This transaction was executed in multiple trades at prices ranging from $291.71 to $292.62. The price reported reflects the weighted average sale price."}],"balance_after":39202,"source":{"system":"sec-edgar","filing":"0001156039-20-000086","document":"wf-form4_160313949706885.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1156039/000115603920000086/wf-form4_160313949706885.xml","form_type":"4"}},{"id":3004240,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":62914,"kind":"person","name":"Haytaian Peter D","position":1,"cik":"0001608538","reported_name":"Haytaian Peter D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & President, Commercial"}}],"security":"Common Stock","published_at":"2020-10-19T20:31:51.000Z","date":"2020-10-15","kind":"sale","acquired":false,"shares":800,"price":290.3,"value":232240.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 14, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $289.81 to $290.79. The price reported reflects the weighted average sale price."}],"balance_after":40802,"source":{"system":"sec-edgar","filing":"0001156039-20-000086","document":"wf-form4_160313949706885.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1156039/000115603920000086/wf-form4_160313949706885.xml","form_type":"4"}},{"id":3004239,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":62914,"kind":"person","name":"Haytaian Peter D","position":1,"cik":"0001608538","reported_name":"Haytaian Peter D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & President, Commercial"}}],"security":"Common Stock","published_at":"2020-10-19T20:31:51.000Z","date":"2020-10-15","kind":"sale","acquired":false,"shares":1000,"price":287.58,"value":287580.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 14, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $287.17 to $287.90. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) through (6) to this Form 4."}],"balance_after":41602,"source":{"system":"sec-edgar","filing":"0001156039-20-000086","document":"wf-form4_160313949706885.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1156039/000115603920000086/wf-form4_160313949706885.xml","form_type":"4"}},{"id":3004238,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":62914,"kind":"person","name":"Haytaian Peter D","position":1,"cik":"0001608538","reported_name":"Haytaian Peter D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & President, Commercial"}}],"security":"Common Stock","published_at":"2020-10-19T20:31:51.000Z","date":"2020-10-15","kind":"exercise","acquired":true,"shares":4667,"price":100.77,"value":470293.59,"ownership":{"direct":true},"balance_after":42602,"source":{"system":"sec-edgar","filing":"0001156039-20-000086","document":"wf-form4_160313949706885.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1156039/000115603920000086/wf-form4_160313949706885.xml","form_type":"4"}},{"id":3008509,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":62914,"kind":"person","name":"Haytaian Peter D","position":1,"cik":"0001608538","reported_name":"Haytaian Peter D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & President, Commercial"}}],"security":"Common Stock","published_at":"2020-10-13T20:31:23.000Z","date":"2020-10-09","kind":"sale","acquired":false,"shares":1167,"price":295,"value":344265.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 14, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $295.00 to $295.07. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":37935,"source":{"system":"sec-edgar","filing":"0001156039-20-000084","document":"wf-form4_160262106970413.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1156039/000115603920000084/wf-form4_160262106970413.xml","form_type":"4"}},{"id":3011856,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":62914,"kind":"person","name":"Haytaian Peter D","position":1,"cik":"0001608538","reported_name":"Haytaian Peter D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & President, Commercial"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2020-10-06T20:30:46.000Z","date":"2020-10-02","kind":"exercise","acquired":false,"shares":2592,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option represents a right to purchase a total of 10,127 shares, and is exercisable in six semi-annual installments with one installment of 1,687 shares and five installments of 1,688 shares each beginning on November 1, 2014, which is the six-month anniversary of the date on which the option was granted."}],"balance_after":5448,"derivative":{"exercise_price":100.77,"expiration_date":"2021-05-01","underlying":"Common Stock","underlying_shares":2592},"source":{"system":"sec-edgar","filing":"0001156039-20-000081","document":"wf-form4_160201623389996.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1156039/000115603920000081/wf-form4_160201623389996.xml","form_type":"4"}},{"id":3011855,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":62914,"kind":"person","name":"Haytaian Peter D","position":1,"cik":"0001608538","reported_name":"Haytaian Peter D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & President, Commercial"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2020-10-06T20:30:46.000Z","date":"2020-10-02","kind":"exercise","acquired":false,"shares":2075,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option represents a right to purchase a total of 11,409 shares, and is exercisable in six semi-annual installments with three installments of 1,901 shares each and three installments of 1,902 shares each beginning on September 3, 2014, which is the six-month anniversary of the date on which the option was granted."}],"balance_after":0,"derivative":{"exercise_price":89.44,"expiration_date":"2021-03-03","underlying":"Common Stock","underlying_shares":2075},"source":{"system":"sec-edgar","filing":"0001156039-20-000081","document":"wf-form4_160201623389996.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1156039/000115603920000081/wf-form4_160201623389996.xml","form_type":"4"}},{"id":3011854,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":62914,"kind":"person","name":"Haytaian Peter D","position":1,"cik":"0001608538","reported_name":"Haytaian Peter D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & President, Commercial"}}],"security":"Common Stock","published_at":"2020-10-06T20:30:46.000Z","date":"2020-10-02","kind":"sale","acquired":false,"shares":4667,"price":280,"value":1306760.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 14, 2020."}],"balance_after":39102,"source":{"system":"sec-edgar","filing":"0001156039-20-000081","document":"wf-form4_160201623389996.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1156039/000115603920000081/wf-form4_160201623389996.xml","form_type":"4"}},{"id":3011853,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":62914,"kind":"person","name":"Haytaian Peter D","position":1,"cik":"0001608538","reported_name":"Haytaian Peter D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & President, Commercial"}}],"security":"Common Stock","published_at":"2020-10-06T20:30:46.000Z","date":"2020-10-02","kind":"exercise","acquired":true,"shares":2592,"price":100.77,"value":261195.84,"ownership":{"direct":true},"balance_after":43769,"source":{"system":"sec-edgar","filing":"0001156039-20-000081","document":"wf-form4_160201623389996.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1156039/000115603920000081/wf-form4_160201623389996.xml","form_type":"4"}},{"id":3011852,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":62914,"kind":"person","name":"Haytaian Peter D","position":1,"cik":"0001608538","reported_name":"Haytaian Peter D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & President, Commercial"}}],"security":"Common Stock","published_at":"2020-10-06T20:30:46.000Z","date":"2020-10-02","kind":"exercise","acquired":true,"shares":2075,"price":89.44,"value":185588.0,"ownership":{"direct":true},"balance_after":41177,"source":{"system":"sec-edgar","filing":"0001156039-20-000081","document":"wf-form4_160201623389996.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1156039/000115603920000081/wf-form4_160201623389996.xml","form_type":"4"}},{"id":3115023,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":62914,"kind":"person","name":"Haytaian Peter D","position":1,"cik":"0001608538","reported_name":"Haytaian Peter D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & President, Commercial"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2020-06-10T20:33:51.000Z","date":"2020-06-08","kind":"exercise","acquired":false,"shares":9334,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option represents a right to purchase a total of 11,409 shares, and is exercisable in six semi-annual installments with three installments of 1,901 shares and three installments of 1,902 shares each beginning on September 3, 2014, which is the six-month anniversary of the date on which the option was granted."}],"balance_after":2075,"derivative":{"exercise_price":89.44,"expiration_date":"2021-03-03","underlying":"Common Stock","underlying_shares":9334},"source":{"system":"sec-edgar","filing":"0001156039-20-000059","document":"wf-form4_159182121303810.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1156039/000115603920000059/wf-form4_159182121303810.xml","form_type":"4"}},{"id":3115022,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":62914,"kind":"person","name":"Haytaian Peter D","position":1,"cik":"0001608538","reported_name":"Haytaian Peter D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & President, Commercial"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2020-06-10T20:33:51.000Z","date":"2020-06-08","kind":"exercise","acquired":false,"shares":2087,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option represents a right to purchase a total of 10,127 shares, and is exercisable in six semi-annual installments with one installment of 1,687 shares and five installments of 1,688 shares each beginning on November 1, 2014, which is the six-month anniversary of the date on which the option was granted."}],"balance_after":8040,"derivative":{"exercise_price":100.77,"expiration_date":"2021-05-01","underlying":"Common Stock","underlying_shares":2087},"source":{"system":"sec-edgar","filing":"0001156039-20-000059","document":"wf-form4_159182121303810.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1156039/000115603920000059/wf-form4_159182121303810.xml","form_type":"4"}},{"id":3115021,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":62914,"kind":"person","name":"Haytaian Peter D","position":1,"cik":"0001608538","reported_name":"Haytaian Peter D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & President, Commercial"}}],"security":"Common Stock","published_at":"2020-06-10T20:33:51.000Z","date":"2020-06-08","kind":"sale","acquired":false,"shares":14001,"price":300,"value":4200300.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 25, 2020."}],"balance_after":39102,"source":{"system":"sec-edgar","filing":"0001156039-20-000059","document":"wf-form4_159182121303810.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1156039/000115603920000059/wf-form4_159182121303810.xml","form_type":"4"}},{"id":3115020,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":62914,"kind":"person","name":"Haytaian Peter D","position":1,"cik":"0001608538","reported_name":"Haytaian Peter D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & President, Commercial"}}],"security":"Common Stock","published_at":"2020-06-10T20:33:51.000Z","date":"2020-06-08","kind":"exercise","acquired":true,"shares":9334,"price":89.44,"value":834832.96,"ownership":{"direct":true},"balance_after":53103,"source":{"system":"sec-edgar","filing":"0001156039-20-000059","document":"wf-form4_159182121303810.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1156039/000115603920000059/wf-form4_159182121303810.xml","form_type":"4"}},{"id":3115019,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":62914,"kind":"person","name":"Haytaian Peter D","position":1,"cik":"0001608538","reported_name":"Haytaian Peter D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & President, Commercial"}}],"security":"Common Stock","published_at":"2020-06-10T20:33:51.000Z","date":"2020-06-08","kind":"exercise","acquired":true,"shares":2087,"price":100.77,"value":210306.99,"ownership":{"direct":true},"balance_after":43769,"source":{"system":"sec-edgar","filing":"0001156039-20-000059","document":"wf-form4_159182121303810.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1156039/000115603920000059/wf-form4_159182121303810.xml","form_type":"4"}},{"id":3228106,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":62914,"kind":"person","name":"Haytaian Peter D","position":1,"cik":"0001608538","reported_name":"Haytaian Peter D","relationship":{"officer":true,"officer_title":"EVP & President, Commercial"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2020-03-04T21:39:57.000Z","date":"2020-03-02","kind":"grant","acquired":true,"shares":15926,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option represents a right to purchase a total of 15,926 shares, and is exercisable in three annual installments, with one installment of 5,308 shares and two installments of 5,309 shares each, beginning on 3/2/2021, which is the one-year anniversary of the option grant date."}],"balance_after":15926,"derivative":{"exercise_price":271.27,"expiration_date":"2030-03-02","underlying":"Common Stock","underlying_shares":15926},"source":{"system":"sec-edgar","filing":"0001127602-20-009435","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1156039/000112760220009435/form4.xml","form_type":"4"}},{"id":3228105,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":62914,"kind":"person","name":"Haytaian Peter D","position":1,"cik":"0001608538","reported_name":"Haytaian Peter D","relationship":{"officer":true,"officer_title":"EVP & President, Commercial"}}],"security":"Common Stock","published_at":"2020-03-04T21:39:57.000Z","date":"2020-03-02","kind":"grant","acquired":true,"shares":37420,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents performance based restricted share units. Restrictions lapse on 3/2/2020."}],"balance_after":41682,"source":{"system":"sec-edgar","filing":"0001127602-20-009435","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1156039/000112760220009435/form4.xml","form_type":"4"}},{"id":3228104,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":62914,"kind":"person","name":"Haytaian Peter D","position":1,"cik":"0001608538","reported_name":"Haytaian Peter D","relationship":{"officer":true,"officer_title":"EVP & President, Commercial"}}],"security":"Common Stock","published_at":"2020-03-04T21:39:57.000Z","date":"2020-03-02","kind":"grant","acquired":true,"shares":2996,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents restricted share units. Restrictions lapse as follows: 998 shares on 3/2/2021, and 999 shares each on 3/2/2022 and 3/2/2023."}],"balance_after":4262,"source":{"system":"sec-edgar","filing":"0001127602-20-009435","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1156039/000112760220009435/form4.xml","form_type":"4"}},{"id":3228103,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":62914,"kind":"person","name":"Haytaian Peter D","position":1,"cik":"0001608538","reported_name":"Haytaian Peter D","relationship":{"officer":true,"officer_title":"EVP & President, Commercial"}}],"security":"Common Stock","published_at":"2020-03-04T21:39:57.000Z","date":"2020-03-02","kind":"tax_withholding","acquired":false,"shares":19683,"price":271.27,"value":5339407.41,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK."}],"balance_after":1266,"source":{"system":"sec-edgar","filing":"0001127602-20-009435","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1156039/000112760220009435/form4.xml","form_type":"4"}},{"id":3331466,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":62914,"kind":"person","name":"Haytaian Peter D","position":1,"cik":"0001608538","reported_name":"Haytaian Peter D","relationship":{"officer":true,"officer_title":"EVP & President, Commercial"}}],"security":"Common Stock","published_at":"2019-12-26T19:42:50.000Z","date":"2019-12-24","kind":"sale","acquired":false,"shares":4166,"price":303.82,"value":1265714.12,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on July 25, 2019."}],"balance_after":20949,"source":{"system":"sec-edgar","filing":"0001127602-19-035835","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1156039/000112760219035835/form4.xml","form_type":"4"}},{"id":3331465,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":62914,"kind":"person","name":"Haytaian Peter D","position":1,"cik":"0001608538","reported_name":"Haytaian Peter D","relationship":{"officer":true,"officer_title":"EVP & President, Commercial"}}],"security":"Common Stock","published_at":"2019-12-26T19:42:50.000Z","date":"2019-12-20","kind":"sale","acquired":false,"shares":4167,"price":303.32,"value":1263934.44,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on July 25, 2019."}],"balance_after":25115,"source":{"system":"sec-edgar","filing":"0001127602-19-035835","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1156039/000112760219035835/form4.xml","form_type":"4"}},{"id":3364467,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":62914,"kind":"person","name":"Haytaian Peter D","position":1,"cik":"0001608538","reported_name":"Haytaian Peter D","relationship":{"officer":true,"officer_title":"EVP & President, Commercial"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2019-11-21T00:04:53.000Z","date":"2019-11-18","kind":"exercise","acquired":false,"shares":3762,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option represents a right to purchase a total of 7,523 shares, and is exercisable in six semi-annual installments, with one installment of 1,253 shares and five installments of 1,254 shares each, beginning on September 1, 2013, which is the six-month anniversary of the option grant date."}],"balance_after":0,"derivative":{"exercise_price":61.88,"expiration_date":"2020-03-01","underlying":"Common Stock","underlying_shares":3762},"source":{"system":"sec-edgar","filing":"0001127602-19-033441","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1156039/000112760219033441/form4.xml","form_type":"4"}},{"id":3364466,"issuer":{"id":2934,"kind":"organization","name":"Elevance Health, Inc.","symbol":"ELV"},"owners":[{"id":62914,"kind":"person","name":"Haytaian Peter D","position":1,"cik":"0001608538","reported_name":"Haytaian Peter D","relationship":{"officer":true,"officer_title":"EVP & President, Commercial"}}],"security":"Common Stock","published_at":"2019-11-21T00:04:53.000Z","date":"2019-11-18","kind":"sale","acquired":false,"shares":12095,"price":300,"value":3628500.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on July 25, 2019."}],"balance_after":29282,"source":{"system":"sec-edgar","filing":"0001127602-19-033441","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1156039/000112760219033441/form4.xml","form_type":"4"}}],"next_cursor":"2019-11-21T00:04:53.000000Z,3364466"}